Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1990-8-1
pubmed:abstractText
The T cell receptor alpha/beta (TCR-alpha/beta) is encoded by variable (V), diversity (D), joining (J), and constant (C) segments assembled by recombination during thymocyte maturation to produce a heterodimer that imparts antigenic specificity to the T cell. Unlike immunoglobulins (Igs), which bind free antigen, the ligands of TCR-alpha/beta are cell surface complexes of intracellularly degraded antigens (i.e., peptides) bound to and presented by polymorphic products of the major histocompatibility complex (MHC). Therefore, antigen recognition by T cells is defined as MHC restricted. A model has been formulated based upon the similarity between TCR-alpha/beta V region and Ig Fab amino acid sequences, and the crystal structure of the MHC class I and Ig molecules. This model predicts that the complementarity determining regions (CDR) 1 and 2, composed of TCR V alpha and V beta segments, primarily contact residues of the MHC alpha helices, whereas V/J alpha and V/D/J beta junctional regions (the CDR3 equivalent) contact the peptide in the MHC binding groove. Because polymorphism in MHC proteins is limited relative to the enormous diversity of antigenic peptides, the TCR may have evolved to position the highly diverse junctional residues (CDR3), where they have maximal contact with antigen bound in the MHC peptide groove. Here, we demonstrate a definitive association between CDR3 sequences in both TCR alpha and beta chains, and differences in recognition of antigen fine specificity using a panel of I-Ed-restricted, myoglobin-reactive T cell clones. Acquisition of these data relied in part upon a modification of the polymerase chain reaction that uses a degenerate, consensus primer to amplify TCR alpha chains without foreknowledge of the V alpha segments they utilize.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/1694219-2412120, http://linkedlifedata.com/resource/pubmed/commentcorrection/1694219-2439105, http://linkedlifedata.com/resource/pubmed/commentcorrection/1694219-2448875, http://linkedlifedata.com/resource/pubmed/commentcorrection/1694219-2453567, http://linkedlifedata.com/resource/pubmed/commentcorrection/1694219-2455603, http://linkedlifedata.com/resource/pubmed/commentcorrection/1694219-2456856, http://linkedlifedata.com/resource/pubmed/commentcorrection/1694219-2456857, http://linkedlifedata.com/resource/pubmed/commentcorrection/1694219-2501444, http://linkedlifedata.com/resource/pubmed/commentcorrection/1694219-2580901, http://linkedlifedata.com/resource/pubmed/commentcorrection/1694219-2594067, http://linkedlifedata.com/resource/pubmed/commentcorrection/1694219-271968, http://linkedlifedata.com/resource/pubmed/commentcorrection/1694219-2832942, http://linkedlifedata.com/resource/pubmed/commentcorrection/1694219-2849763, http://linkedlifedata.com/resource/pubmed/commentcorrection/1694219-2953795, http://linkedlifedata.com/resource/pubmed/commentcorrection/1694219-2965094, http://linkedlifedata.com/resource/pubmed/commentcorrection/1694219-2971753, http://linkedlifedata.com/resource/pubmed/commentcorrection/1694219-2995827, http://linkedlifedata.com/resource/pubmed/commentcorrection/1694219-3012351, http://linkedlifedata.com/resource/pubmed/commentcorrection/1694219-3043226, http://linkedlifedata.com/resource/pubmed/commentcorrection/1694219-3075592, http://linkedlifedata.com/resource/pubmed/commentcorrection/1694219-3208747, http://linkedlifedata.com/resource/pubmed/commentcorrection/1694219-3258651, http://linkedlifedata.com/resource/pubmed/commentcorrection/1694219-3431465, http://linkedlifedata.com/resource/pubmed/commentcorrection/1694219-3461561, http://linkedlifedata.com/resource/pubmed/commentcorrection/1694219-3490536, http://linkedlifedata.com/resource/pubmed/commentcorrection/1694219-3493320, http://linkedlifedata.com/resource/pubmed/commentcorrection/1694219-3518750, http://linkedlifedata.com/resource/pubmed/commentcorrection/1694219-3598467, http://linkedlifedata.com/resource/pubmed/commentcorrection/1694219-518835, http://linkedlifedata.com/resource/pubmed/commentcorrection/1694219-6158548, http://linkedlifedata.com/resource/pubmed/commentcorrection/1694219-6170716, http://linkedlifedata.com/resource/pubmed/commentcorrection/1694219-6198242, http://linkedlifedata.com/resource/pubmed/commentcorrection/1694219-6198391, http://linkedlifedata.com/resource/pubmed/commentcorrection/1694219-6206178, http://linkedlifedata.com/resource/pubmed/commentcorrection/1694219-6312838, http://linkedlifedata.com/resource/pubmed/commentcorrection/1694219-6611207, http://linkedlifedata.com/resource/pubmed/commentcorrection/1694219-6791833
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0022-1007
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
172
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
27-33
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1990
pubmed:articleTitle
The presumptive CDR3 regions of both T cell receptor alpha and beta chains determine T cell specificity for myoglobin peptides.
pubmed:affiliation
Department of Medicine, Stanford University School of Medicine, California 94305.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't